Partnerships & Alliances | Wednesday, June 24 2009
Cambridge Heart has signed a non-exclusive development and distribution agreement with an undisclosed U.S. stress test manufacturer to develop a microvolt T-Wave alternans module.
Top Stories | Wednesday, June 24 2009
Democrats in the U.S. House of Representatives unveiled their healthcare reform legislation Friday, calling for a 75 percent increase in the equipment utilization rate and an increase of 25 to 50 percent in the reduction of the technical component of imaging for multiple procedures.
Industry News | Tuesday, June 23 2009
The Institute for Molecular Technologies, a council of the Academy of Molecular Imaging (AMI), on Friday introduced the ACE Awareness, Communication and Education program developed to generate awareness and enhance the quality of PET imaging. The ACE kits, which address all indications covered by the Centers for Medicare & Medicaid Services (CMS) for PET imaging, will be available July 1.
Regulatory News | Tuesday, June 23 2009
Spectranetics has received the CE Mark approval for its next-generation ThromCat XT thrombus removal system, a single-use, disposable device used to remove the thrombus from native coronary arteries and infra-inguinal arteries.
Financial News | Tuesday, June 23 2009
The European diabetes diagnostics market is poised for expansion with segments such as self-monitoring and point-of-care tests offering tremendous growth potential, according to a report from market research firm Frost & Sullivan.
Regulatory News | Tuesday, June 23 2009
Abbott has received CE Mark for its next-generation Xience Prime everolimus-eluting coronary stent system for the treatment of coronary artery disease. The company plans to launch Xience Prime in a varied size matrix, with lengths up to 38 mm, in the third quarter across Europe.
New Products | Monday, June 22 2009
AccessClosure has released its newest addition to the Mynx vascular closure family, the Mynx M5.
Clinical Studies | Monday, June 22 2009
Rates of death and hospital admissions for cardiovascular (CV) disease declined 30 percent over a 10-year period in Canada, according to a study published online June 22 in Canadian Medical Association Journal, pointing to efforts to prevent heart disease. However, for the first time, more women than men are dying of CV causes.
Regulatory News | Monday, June 22 2009
Medtronic has received the European CE Mark for its second-generation pacemaker for use with MRI machines, the Advisa DR MRI SureScan pacing system.
Top Stories | Monday, June 22 2009
President Barack Obama Sunday released plans to cut in half the prescription drug expenses of Medicare Part D beneficiaries who have reached the coverage gap (doughnut hole) in their prescription benefit. Simultaneously, pharmaceutical companies have agreed to foot the bill for $80 billion in Medicare drugs over the next decade for this population.